Why are older people more at risk of serious pulmonary complications following SARS-CoV-2 infection? The authors of a paper published in the prestigious scientific journal *Science Immunology* answer this question. The article’s co-author is mgr Natalia Stachura-Chyła, a doctoral student at the Department of Molecular Virology of the Intercollegiate Faculty of Biotechnology UG and MUG.
The paper, entitled “Platelet-derived serotonin drives age-related lung pathology in SARS-CoV-2 infection”, presents a mechanism that may explain why coronavirus infection leads to more severe respiratory distress in older people. Studies carried out on mice have shown that serotonin released by platelets plays a significant role in this process.
During the study, the researchers observed that, in older mice, serotonin enhanced platelet activation and promoted the deposition of fibrin in the small pulmonary blood vessels. This process disrupted their function, contributing to a deterioration in lung function. Importantly, following platelet activation, the platelets of older mice, as well as those of older healthy donors, released more serotonin than the platelets of younger mice and donors.
The researchers also investigated whether interfering with this mechanism could limit lung damage. It turned out that inhibiting serotonin uptake or signalling, as well as reducing fibrin formation, alleviated the course of the disease in infected mice. The results therefore point to platelet-derived serotonin as a potential therapeutic target in the treatment of pulmonary complications of COVID-19, particularly in older people.
Research as part of the Preludium Bis project
The results presented in the publication were obtained during a research placement undertaken by Natalia Stachura-Chyła, mgr, at the San Raffaele Scientific Institute in Milan. The placement was carried out as part of a project funded by the Preludium Bis programme.
‘Science Immunology’ is a scientific journal published by the American Association for the Advancement of Science (AAAS), dedicated to research in the field of immunology. The journal’s five-year Impact Factor is 17.5.
About the publication
Title: ‘Platelet-derived serotonin drives age-related lung pathology in SARS-CoV-2 infection’
Journal: “Science Immunology”, 2026
Authors: Marotta D, Perucchini C, Grillo M, Fumagalli V, Di Lucia P, Rixon J, Ravà M, Giustini L, Malpighi C, D’Uonnolo G, Scavone M, Mouro V, Abbott C, Stachura-Chyla N, Andreata F, Scalambrino E, Clerici M, Donnici L, Longo Minnolo M, Inverso D, De Francesco R, Gaya M, Ruggeri ZM, Tripodi A, Podda GM, Guidotti LG, Iannacone M, De Giovanni M
DOI: 10.1126/sciimmunol.aec9853
The article is available on the Science Immunology website